Welcome to the site of the Greiff lab at the Institute of Clinical Medicine (University of Oslo), Norway.

Our research focuses on developing novel computational and experimental strategies for designing next-generation therapeutics, diagnostics and vaccines by combining high-throughput single-cell antibody and T-cell receptor sequencing with artificial intelligence and high-dimensional statistics. Our ultimate aim is to improve public health by decreasing the burden that infectious and autoimmune diseases and cancer impose on humanity.

We aspire to (i) consistent excellence in research and teaching, (ii) inclusive and global team science within both academia and industry and (iii) maximal openness of our research results.